Using both corticosteroids and plasma exchange therapy — each a standard treatment for acquired thrombotic thrombocytopenic purpura (TTP) — together was found to significantly…
News
IMMUNE THROMBOCYTOPENIA
NewsTailored blood thinning helps man, 65, with ITP, recurrent strokes
A man in his 60s with immune thrombocytopenia (ITP) experienced repeated strokes even while taking anticoagulant medications — commonly known as blood thinners —…
VON WILLEBRAND DISEASE
NewsResearch finds bleeding severity varies widely in type 2 VWD
The severity of bleeding in type 2 von Willebrand disease (VWD) can vary widely between subtypes and even among patients who carry the same…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsTTP symptoms vary, but prevention helps control them: Study
The congenital form of thrombotic thrombocytopenic purpura (TTP) can look very different in one person than in another, but preventive treatment can help reduce…
IMMUNE THROMBOCYTOPENIA
NewsITP Awareness Month focuses attention on rare bleeding disorder
Patients, caregivers, medical professionals, and other advocates are coming together in September for Immune Thrombocytopenia Awareness Month to raise awareness and support for a…
VON WILLEBRAND DISEASE
NewsImpacts on quality of life of children with VWD vary based on age
Children with von Willebrand disease (VWD) have reduced health-related quality of life, although the specific areas that seem to be most affected depend on…
IMMUNE THROMBOCYTOPENIA
News1st BTK inhibitor rilzabrutinib, now Wayrilz, approved in US for ITP
Note: This story was updated Sept. 2, 2025, to clarify the definition of a durable platelet response used in LUNA 3. The U.S. Food and…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsAn early diagnosis helps woman with TTP deliver healthy baby
A woman in Spain delivered a full-term, healthy baby after she was identified early as having congenital thrombotic thrombocytopenic purpura (TTP) and treated successfully…
IMMUNE THROMBOCYTOPENIA
NewsDaratumumab injection therapy for cancer may help in hard-to-treat ITP
Daratumumab, an injection therapy approved to treat myeloma, may help to control immune thrombocytopenia (ITP) in individuals whose disease doesn’t respond well to available…
VON WILLEBRAND DISEASE
NewsNew funding will launch trial of tAN for heavy menstrual bleeding
Spark Biomedical has been awarded funding from The Missed Vital Sign, Wellcome Leap’s $50 million program in women’s health, which it will use…
Recent Posts
- Newborn boy’s unusual bleeding leads to rare von Willebrand diagnosis
- ADAMTS13 enzyme key to pregnancy success in TTP rat study
- SYK inhibitors show promise as chronic primary ITP treatment option: Study
- VWD, hemophilia carriers may face slower postpartum recovery
- Guest Voice: The VWD diagnosis that changed how we live
